Use of erythropoietin in ischemic and arrhythmic cardiopathy of hemodialyzed patients.
Bellinghieri
G
G
Chair of Nephrology, University of Messina, Italy.
Savica
V
V
De Gregorio
C
C
De Gregorio
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D000787:Angina Pectoris / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000628:therapy*; D004341:Drug Evaluation; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000209:etiology / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects
D007155:Immunologic Factors; D011994:Recombinant Proteins; D004921:Erythropoietin